MedPath

Effect of a Protein-enriched Drink on Muscle Function

Early Phase 1
Conditions
Contracture
Registration Number
NCT02385357
Lead Sponsor
Puleva Biotech
Brief Summary

There is no conclusive evidence about the effect of intake of protein-enriched drink after and acute high intensity exercise bout on muscle function and damage. The investigators aimed to study the effect of a protein-enriched drink on muscle function recovery following an acute high intensity exercise bout. The present counterbalanced, crossover, and double blind study will involve a total of 12 active men.

Detailed Description

Participants will run downhill (-10%) during 30 min at a intensity equivalent to 75-80% of their maximum heart rate (previously determined). After the exercise bout, participants will have either the placebo or the experimental drink. The investigators will measure muscle function and damage-related parameters right after the exercise as well as the three following days. This protocol will be repeated after a wash out period of 3 weeks, where the participants will have the other drink. The investigators will control exercise and diet three weeks before study entry, during the experimental week as the investigators as during the wash out period.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • Recreational triathletes with 2 years of experience
  • Maximum oxygen uptake : ≥55 ml/kg/min
  • Fat mass: 8-20% measured by dual energy x-ray absorptiometry
  • Not participating in another study
  • Not having ergogenic aids
  • Not participating in a weight loss program
  • Normal electrocardiogram
  • Participants must be capable and willing to provide consent, understand exclusion criteria and accept the randomized group assignment
Exclusion Criteria
  • History of cardiovascular disease
  • Diabetes or hypertension
  • Medication for hypertension, hyperlipidemia, hyperuricemia or other illness.
  • Smoking
  • Other significant medical conditions that are life-threatening or that can interfere with or be aggravated by exercise.
  • Unwillingness to either complete the study requirements or to be randomized into control or training group.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Isometric muscle strengthChange from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink

Isometric muscle strength of lower limbs at 90% angle.

Secondary Outcome Measures
NameTimeMethod
Power output assessed with the 30sec. Wingate anaerobic testChange from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink

Power output will be assessed with the 30sec. Wingate anaerobic test.

Urine CreatinineChange from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink

Concentration of creatinine in urine will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout

Resting metabolic rateChange from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Creatine kinaseChange from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink

Creatine kinase will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout

Muscle soreness of lower limbs self-reported by a visual anagogic scale and with an algometer score.Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink

Muscle soreness of the lower limbs will be self-reported by a visual anagogic scale and with an algometer score.

Time limit (time that the participant is able to run 90% of his determined maximum aerobic velocity)24hrs after protein-enriched drink

We will measure the time that the participant is able to run 90% of his determined maximum aerobic velocity

Trial Locations

Locations (1)

Biosearch Life

🇪🇸

Granada, Spain

Biosearch Life
🇪🇸Granada, Spain
Federico Lara, PhD
Contact
0034958240100
Federico.LaraVilloslada@puleva.es

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.